Skeletal development and remodeling in health, disease, and aging /
Saved in:
| Imprint: | Boston, Mass. : Blackwell Pub. on behalf of the New York Academy of Sciences, 2006. |
|---|---|
| Description: | xviii, 575 p. : ill. ; 24 cm. |
| Language: | English |
| Series: | Annals of the New York Academy of Sciences ; v. 1068 |
| Subject: | |
| Format: | E-Resource Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/6009591 |
Table of Contents:
- Part I. Skeletal Development
- 1. PTHrP and Skeletal Development
- 2. Regulating Bone Growth with BMPs
- 3. BMP and BMP Inhibitors in Bone
- 4. BMP Signaling and Skeletalogensis
- 5. Function of BMP and BMP Antagonist in Adult Bone
- 6. Dysregulation of the BMP4 Signaling Pathway in Fibrodysplasia Ossificans Progressiva
- 7. Hypoxia, HIF-1???? and VHL in Chondrogenesis
- 8. Cellular and Molecular Mechanisms of Synovial Joint and Articular Cartilage Formation
- 9. Multiple Roles of Hoxc8 in Skeletal Development
- Part II. Skeletal Remodeling
- 10. Osteoclasts and Integrins
- 11. Regulation of Osteoclast Differentiation
- 12. Signaling in Osteoclast and their Precursors
- 13. Canonical Wnt Signaling in Osteoblasts is Required for Osteoclast Differentiation
- 14. Inhibition of ATF4 Transcriptional Activity by TIAT/????-Taxilin Modulates Bone Mass
- 15. Paget's Disease of Bone and Genetic Disorders of RANK/OPG/RANK/NF-????B signaling
- 16. The Regulation of Cathepsin K Gene Expression
- 17. Direct and Indirect Estrogen Actions on Osteoblasts and Osteoclasts
- 18. Molecular Mechanism of the Life and Death of the Osteoclast
- 19. Understanding Parathyroid Hormone Action
- 20. New Insights Into the Mechanisms Involved in The Pleiotropic Actions of 1,25dihydroxyvitamin D3
- 21. Mechanisms of Vitamin D Receptor Action
- 22. Role of Connexin 43 in Osteoblast Response to Physical Load
- 23. Interactive Effect of Interleukin-6 and Prostaglandin E2 on Osteoclastogenesis via the OPG/RANK-L/RANK System
- 24. Does TNF Have Anti-Osteoclastogenic Actions?
- 25. Eosinophil Chemotactic Factor-L (ECF-L) Enhances Osteoclast Formation by Increasing ICAM-1 Expression
- Part III. Mechanisms Of Bone Loss
- 26. Bone Cell Precursors and the Pathophysiology of Bone Loss
- 27. Autosomal Dominant Pseudohypoparathyroidism Type 1b is Caused by Different Microdeletions Within or Upstream of the GNAS Locus
- 28. Estrogen Regulation of Immune Cells Bone Interactions
- 29. Autoimmunity and Bone
- 30. Non-Steroid Immune Modulators and Bone Disease
- 31. Pathogenesis of Osteopenia/Osteoporosis Induced by Highly Active Anti-Retroviral Therapy for AIDS
- 32. Pituitary Hormones and Bone Loss
- 33. Bone Destruction in Multiple Myeloma
- 34. Osteogenic Regulation of Vascular Calcification
- 35. The OPG/TRAIL Complex in an In Vitro Osteoclastogenesis Model Dervied From Human Multiple Myeloma Bone Disease
- 36. Restoration of Bone Mass in hpg Mouse by Preoptic Area Grafting
- 37. IL-7 Drives T Cell-Medicated Bone Loss Following Ovariectomy
- Part IV. Restoring Skeletal Strength
- 38. Stem Cells and Tissue Engineering: Past, Present and Future
- 39. Bisphosphonates: From Bench to Bedside
- 40. Novel Targets and Therapeutics for Bone Loss
- 41. Advanced Imaging Assessment of Bone Quality
- 42. Bone Strength: Current Concepts
- 43. Anti-Catabolic Therapeutic Target in Bone Disease
- 44. Mechanisms Involved in Skeleton Anabolic Therapies
- 45. Misconceptions About Calcimimetics
- 46. Osteoblastic Activation in the Hematopoetic Stem Cell Niche
- 47. Circulating Cells with O
